COMORBIDITY PROFILE AND PHARMACOTHERAPY COMPLIANCE IN POST-COVID-19 ASSOCIATED DIGESTIVE DISEASES: A POPULATION-BASED STUDY IN THE FERGANA REGION OF UZBEKISTAN

Authors

  • Boltaboyev Alisher Murodiljon oʻgʻli Assistant, Department of Internal Medicine No. 1, Central Asian Medical University, Fergana, Uzbekistan Author

Keywords:

Keywords: post-COVID-19 condition, digestive diseases, comorbidity, pharmacoepidemiology, arterial hypertension, anemia, treatment compliance.

Abstract

We assessed comorbidity and drug therapy in Post-COVID-19 associated digestive diseases (DD) among 1,605 adults aged 18-60 years in the Fergana region. Cardiovascular diseases (51.5%), anemia (32.2%) and arterial hypertension (25.3%) formed the main comorbid background. Comorbidity was more frequent in women than in men (55.4% vs 44.6%; P<0.05). Compliance of pharmacotherapy with clinical standards was 87.8% in women and 65.1% in men. A regional program built on these data reduced complication risk by up to 64.9% and stopped inappropriate antibiotic use.

References

1.Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z

2.Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583-590. doi:10.1038/s41591-022-01689-3

3.Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520-531. doi:10.1016/j.cmi.2020.12.018

4.Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-436. doi:10.1038/s41586-020-2521-4

5.Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients (ACTIV SARS-CoV-2)”. Kardiologiia. 2020;60(11):30-34. (In Russian). PMID: 33487147

6.Ivashkin VT, Maev IV, Tsar’kov PV, et al. Diagnosis and treatment of peptic ulcer in adults (clinical guidelines of the Russian Gastroenterological Association). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(1):49-70. (In Russian).

7.Boltaboyev AM. Epidemiology, prevention and improvement of treatment of Post-COVID-19 associated digestive system diseases. PhD dissertation (Medical Sciences). Andijan; 2025. (In Uzbek).

Downloads

Published

2026-10-27